08622 HUAKANG BIOMED
WatchlistHUAKANG BIOMED News
HUAKANG BIOMED: 2023 Third Quarterly Report
HUAKANG BIOMED: THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
HUAKANG BIOMED: 2023 INTERIM REPORT
HUAKANG BIOMED: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
HUAKANG BIOMED: NOTIFICATION OF BOARD MEETING
HUAKANG BIOMED: 2023 First Quarterly Report
HUAKANG BIOMED: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2023
Huakang Biomedical: 2022 Report
Huakang Biomedical: Annual Results Announcement for the Year Ended December 31, 2022
Have Insiders Sold Huakang Biomedical Holdings Company Limited (HKG:8622) Shares Recently?
We note that the Huakang Biomedical Holdings Company Limited (HKG:8622) Vice Chairman, Yim Yang Chang, recently sold HK$101k worth of stock for HK$0.18 per share. On the bright side, that's just a
Huakang Biomedicine: third quarter report 2022
Huakang Biomedicine: nine months ended September 30, 2022 Third quarter results announcement
Biden Signs Order to Curb China in Biotechnology Following Chip Bill
The US government is reported to introduce new regulations next month to prohibit American companies from exporting chipmaking equipment to Chinese factories that produce advanced semiconductors with sub-14 nanometer processes.
Huakang Biomedical Science: 2022 interim report
Huakang Biomedical: interim results announcement for the six months ended June 30, 2022
Huakang Biomedicine: first quarter report 2022
Huakang Biomedical: first quarter results announcement for the three months ended March 31, 2022
Huakang Biomedicine: report 2021
Huakang Biomedicine: annual results announcement for the year ended December 31, 2021
Huakang Biomedicine: notice of Board meeting